Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder

NCT: NCT03969251 · COMPLETED

NCT IDNCT03969251
StatusCOMPLETED
Start Date2019-07-11
Completion2021-02-10

Brief Summary

This is a pilot study designed to evaluate the efficacy of High Frequency (HF) repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (L-DLPFC) at improving cognitive flexibility in recently detoxified individuals with alcohol use disorder (AUD) compared to placebo (Sham rTMS). The total number of subjects requested to be randomized is 20. The investigator will need to screen about 40 subjects to have 20 subjects started on rTMS session at a ratio of 2 screens/1 subject randomized.

Frequently Asked Questions

What is Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder?

Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder is a clinical trial registered under NCT03969251. Current status: COMPLETED.

What is the status of NCT03969251?

The current status of NCT03969251 (Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder) is: COMPLETED.

When did Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder start?

Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder started on 2019-07-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.